MARATTO

article · Current Computer - Aided Drug Design

<i>In silico</i> Exploration of a Novel ICMT Inhibitor with More Solubility than Cysmethynil against Membrane Localization of KRAS Mutant in Colorectal Cancer

20241 citationHassan II University Casablanca

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

According to the results obtained, the identified compound presented a high solubility in water and could be similar to the pharmacological activity of cysmethynil.

Research topics

  • Computational Drug Discovery Methods
  • Pharmacogenetics and Drug Metabolism
  • Cancer, Hypoxia, and Metabolism

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher siteRecord on OpenAlex

DOI: 10.2174/0115734099264451231003172217

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

Sign in to join the discussion

New to MARATTO™? Create a free account.